O'Neil Thomas P.

CIK 00016406453 companiesDAVIS, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001640645

Recent Transactions

44 trades

Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−72,340→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−60,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−190,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−80,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−76,595→ 0 total
Disposition from Tender
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2023-06-06$0.91/sh−13,877→ 0 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-06-03+190,000→ 190,000 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-12-03+80,000→ 80,000 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-09-01$4.56/sh+750→ 750 total
Sale
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-09-01$22.19/sh−750→ 0 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-09-01−750→ 65,590 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-08-05−1,000→ 66,340 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-08-05$4.56/sh+1,000→ 1,000 total
Sale
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-08-05$25.00/sh−1,000→ 0 total
Sale
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-07-01$26.70/sh−394→ 0 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-07-01$4.56/sh+300→ 300 total
Sale
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-07-01$25.63/sh−300→ 0 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-07-01$4.56/sh+394→ 394 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-07-01$4.56/sh+306→ 306 total
Sale
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-07-01$27.59/sh−306→ 0 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-07-01−1,000→ 67,340 total
Sale
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-06-23$35.23/sh−2,115→ 0 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-06-23$1.04/sh+2,115→ 2,115 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-06-23−2,115→ 74,480 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-06-01−1,000→ 68,340 total
Sale
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-06-01$25.32/sh−1,000→ 0 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-06-01$4.56/sh+1,000→ 1,000 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-05-20$4.56/sh+2,000→ 2,000 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-05-20−2,000→ 69,340 total
Sale
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-05-20$25.00/sh−2,000→ 0 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-03-11−1,000→ 71,340 total
Exercise/Conversion
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-03-11$4.56/sh+1,000→ 1,000 total
Sale
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2020-03-11$27.68/sh−1,000→ 0 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-03-04+60,000→ 60,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2018-08-15+21,100→ 30,560 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2018-08-15+14,050→ 14,050 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2018-02-28+6,000→ 8,858 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2018-02-28+34,000→ 34,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2017-12-18$4.21/sh+4,000→ 8,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2017-12-18$1.16/sh+4,000→ 4,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Employee Stock Option (right to buy)
2017-12-18−4,000→ 57,666 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Employee Stock Option (right to buy)
2017-12-18−4,000→ 28,998 total
Sale
Protagonist Therapeutics, Inc$PTGX
12/18/2017
2017-12-18$20.00/sh−8,000→ 0 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2016-10-11+45,000→ 45,000 total

Companies

Recent Filings

Address

C/O ARCADIA BIOSCIENCES, INC. 202 COUSTEAU, SUITE 105

DAVIS, CA, 95618

View on SEC.gov